Bortezomib
- Product NDC
- 75007-501
- 11-digit product format
- 750070501
- Labeler code
- 75007
- Product ID
- 75007-501_1393b9d2-c8d3-49f9-8665-5cc3a083f0c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bortezomib
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Ningbo Shuangcheng Pharmaceutical Co., Ltd.
- Application
- ANDA216528
- Marketing category
- ANDA
- Marketing start
- 2025-12-17
- Substance
- BORTEZOMIB
- Active strength
- 3.5 mg/1
- Pharmacologic classes
- Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bortezomib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BORTEZOMIB | 3.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 69G8BD63PP |
| Rxcui | 402243 |
DailyMed Product Concepts#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 75007-501-31 | 75007050131 | 10 VIAL in 1 CARTON (75007-501-31) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 10 vial | 2025-12-17 | No | No | Current |
| 75007-501-32 | 75007050132 | 1 VIAL in 1 CARTON (75007-501-32) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2025-12-17 | No | No | Current |